Dana Ault-riche PhD

Dana Ault-Riche is CEO of Reflexion Pharmaceuticals, USA. Over his 20-year career, he has started five different biotechnology companies, in each case serving as the CEO for the company. His first three companies, Zyomyx, Diazyme, and Pointilliste, pioneered novel technology tool platforms for use in drug discovery. His last two companies, Ethos and Reflexion, use novel chemistries to discover and advance new molecular entities as therapeutics.

He earned a Ph.D. in Biochemistry (Molecular Genetics) from the University of Kansas under Professor Ronald Borchardt and completed postdoctoral training at Stanford University with Nobel Laureate Professor Arthur Kornberg.